Advances in Clinical Chemistry: Volume 112

CHF 197.95
Auf Lager
SKU
G1T287U3K3B
Stock 1 Verfügbar
Free Shipping Kostenloser Versand
Geliefert zwischen Mi., 05.11.2025 und Do., 06.11.2025

Details

Advances in Clinical Chemistry, Volume 112 highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Heterogeneity in Major Depressive Disorder: The need for Biomarker-based and Personalized Treatments, Advances in exosome analysis, Translational Proteomics and Phosphoproteomics: Tissue to Extracellular Vesicles, Immune Checkpoint Therapy, Tumor Immunology, and Biomarkers in Non-Small-Cell Lung Cancer, Advances in Congestive Heart Failure Biomarkers, Fluid biomarkers in Alzheimer's disease, and more.

Autorentext

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.


Inhalt

  1. Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
    Shayam Suseelan and Graziano Pinna
  2. Advances in exosome analysis
    Arnau Pallares-Rusiñol, Mireia Bernuz, Silio Lima Moura, Carolina Fernández-Senac, Rosanna Rossi, Mercè Martí, and María Isabel Pividori
  3. Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles
    Xiaofeng Wu, Anton B. Iliuk, and W. Andy Tao
  4. Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
    Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase, Ryo Tanaka, Takayuki Suetsugu, Keiko Mizuno, Takehiro Hasegawa, Yusuke Atarashi, Yasuhiro Irino, Toshiyuki Sato, Hiromasa Inoue, Noboru Hattori, Eiichiro Kanda, Masao Nakata, Hiroshi Mukae, Toru Oga, and Mikio Oka
  5. Advances in congestive heart failure biomarkers
    Iyyapu Krishna Mohan, K.S.S. Sai Baba, Rohit Iyyapu, Sunitha Thirumalasetty, and O. Sai Satish
  6. Fluid biomarkers in Alzheimer's disease
    Joel Simr
Cart 30 Tage Rückgaberecht
Cart Garantie

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09780443192845
    • Genre Chemistry
    • Editor Gregory S. Makowski
    • Herausgeber Elsevier Science & Technology
    • Größe H229mm x B152mm x T22mm
    • Jahr 2023
    • EAN 9780443192845
    • Format Fester Einband
    • ISBN 978-0-443-19284-5
    • Veröffentlichung 11.01.2023
    • Titel Advances in Clinical Chemistry: Volume 112
    • Gewicht 590g
    • Sprache Englisch

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.